PharmaShots | Incisive News in 3 Shots

Subscribe Now

All Posts by Date

Insights+: EMA Marketing Authorization of New Drugs in January 2023

Insights+: EMA Marketing Authorization of New Drugs in January 2023

February 23, 2023

AbbVie Expands its Collaboration with Capsida Biotherapeutics to Develop Targeted Genetic Therapies for Eye Diseases

AbbVie Expands its Collaboration with Capsida Biotherapeutics to Develop Targeted Genetic Therapies for Eye Diseases

February 23, 2023

AstraZeneca’s Tezspire (tezepelumab) Receives the EU Approval for the Treatment of Severe Asthma

AstraZeneca’s Tezspire (tezepelumab) Receives the EU Approval for the Treatment of Severe Asthma

February 23, 2023

Pfizer’s Reports the US FDA and EMA’s Acceptance of BLA and MAA for Elranatamab for Multiple Myeloma

Pfizer’s Reports the US FDA and EMA’s Acceptance of BLA and MAA for Elranatamab for Multiple Myeloma

February 23, 2023

Keymed and Lepu Biopharma Enter into an Exclusive License Agreement with AstraZeneca for CMG901 to Treat Claudin 18.2-Positive Solid Tumors

Keymed and Lepu Biopharma Enter into an Exclusive License Agreement with AstraZeneca for CMG901 to Treat Claudin 18.2-Positive Sol...

February 23, 2023

EMA Adopts Positive Opinion for Bekemv (biosimilar, eculizumab) to Treat Paroxysmal Nocturnal Haemoglobinuria

EMA Adopts Positive Opinion for Bekemv (biosimilar, eculizumab) to Treat Paroxysmal Nocturnal Haemoglobinuria

February 23, 2023

Contact Us

First Floor, B 150, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
[email protected]
Newsletter

Our Information

Follow Us